Modern Water Buys Cogent Environmental

Water/wastewater

Modern Water Buys Cogent Environmental

11 Mar, 2011

Published over 15 years ago. See the latest and most current information on Water/wastewater.

Modern Water (UK), the owner of leading water technologies focused on addressing the scarcity of fresh water, the treatment of wastewater, and monitoring of water quality, announces the purchase on 2nd February 2011 of the entire share capital of the private company Cogent Environmental Limited (“Cogent Environmental”) from the private equity investor, Sultan Scientific Limited (the majority shareholder) and its nine other existing shareholders.

Cogent Environmental is a global provider of state-of-the-art environmental and process monitoring products, technologies and services. Its online and portable products, OVA and PDV, are used for monitoring heavy metals in over 20 countries. Key market sectors include natural resources and energy, heavy industry and manufacturing, public and private utilities, and environmental regulation.

The acquisition represents an important strategic step for Modern Water’s existing water monitoring business, Cymtox, and significantly increases the Group’s offering in this developing market segment. As a result, Modern Water has established a new dedicated division, MW Monitoring, to consolidate our activities in the instrumentation and monitoring industry. Cymtox has already enjoyed initial order flow from China and new sales have recently been achieved.

Latest News

IET 36.3 May

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Labmate Online
Review suggests eating less protein could extend healthy lifespan in inactive adults
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Petro Online
ASTM D8615 brings automated freezing-point testing into aviation fuel laboratories
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow